Name | 4-(4-Octadecylphenyl)-4-oxo-2-butenoic acid |
---|---|
Synonyms |
(2E)-4-(4-Octadecylphenyl)-4-oxo-2-butenoic acid
2-Butenoic acid, 4-(4-octadecylphenyl)-4-oxo-, (2E)- (2E)-4-(4-Octadecylphenyl)-4-oxobut-2-enoic acid 4-(4-Octadecylphenyl)-4-oxo-2-butenoic acid |
Description | (2E)-OBAA is a potent phospholipase A2 (PLA2) inhibitor, with an IC50 of 70 nM. (2E)-OBAA induces apoptosis of HUVEC cells. (2E)-OBAA blocks Melittin-induced Ca2+ influx in Trypanosoma brucei, with an IC50 of 0.4 μM[1][2][3][4]. |
---|---|
Related Catalog | |
Target |
PLA2:70 nM (IC50) |
In Vitro | (2E)-OBAA (5.7 μM) induces apoptotic cell death of human umbilical vein endothelial cells (HUVEC). After 16 h of treatment, almost all of the cells has disintegrated into apoptotic bodies[1]. |
In Vivo | (2E)-OBAA (2.5-7 mg/kg, IV) significantly and dose-dependently inhibits the immunologically induced bronchospasm in guinea pigs[3]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 558.6±50.0 °C at 760 mmHg |
Molecular Formula | C28H44O3 |
Molecular Weight | 428.647 |
Flash Point | 305.7±26.6 °C |
Exact Mass | 428.329041 |
LogP | 11.09 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.508 |